Showing 1 - 20 results of 28 for search 'Hans Peter Hartung', query time: 0.04s
Refine Results
-
1
-
2
Editorial: CNS autoimmune disorders and COVID-19 by Omid Mirmosayyeb, Shervin Badihian, Vahid Shaygannejad, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung
Published 2023-04-01
Article -
3
-
4
-
5
B cell targeted therapies in inflammatory autoimmune disease of the central nervous system by Moritz J. Furman, Sven G. Meuth, Philipp Albrecht, Philipp Albrecht, Michael Dietrich, Heike Blum, Jan Mares, Ron Milo, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung
Published 2023-03-01
Article -
6
Type O blood group associates with higher anti‐JC polyomavirus antibody levels by Pia Frenken, Hans‐Peter Hartung, Tomas Olsson, Ortwin Adams, Clemens Warnke
Published 2021-08-01
Article -
7
Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review by Óscar Fernández, Óscar Fernández, Per Soelberg Sörensen, Per Soelberg Sörensen, Giancarlo Comi, Giancarlo Comi, Patrick Vermersch, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Letizia Leocani, Letizia Leocani, Thomas Berger, Thomas Berger, Bart Van Wijmeersch, Bart Van Wijmeersch, Celia Oreja-Guevara, Celia Oreja-Guevara
Published 2024-04-01
Article -
8
Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab by Saskia Räuber, Alice Willison, Melanie Korsen, Tristan Kölsche, Kristin S. Golombeck, Benedikt Plaack, Julia Schüller, Niklas Huntemann, Leoni Rolfes, Christina B. Schroeter, Christopher Nelke, Liesa Regner-Nelke, Moritz Förster, Marius Ringelstein, Marius Ringelstein, Michael Harry Barnett, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Orhan Aktas, Philipp Albrecht, Tobias Ruck, Nico Melzer, Sven G. Meuth, David Kremer
Published 2022-12-01
Article -
9
-
10
The Molecular Basis for Remyelination Failure in Multiple Sclerosis by Joel Gruchot, Vivien Weyers, Peter Göttle, Moritz Förster, Hans-Peter Hartung, Patrick Küry, David Kremer
Published 2019-08-01
Article -
11
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in by Maura Pugliatti, Maura Pugliatti, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Celia Oreja-Guevara, Celia Oreja-Guevara, Carlo Pozzilli, Laura Airas, Laura Airas, Mona Alkhawajah, Mona Alkhawajah, Nikolaos Grigoriadis, Melinda Magyari, Bart Van Wijmeersch, Bart Van Wijmeersch, Bart Van Wijmeersch, Magd Zakaria, Ralf Linker, Andrew Chan, Patrick Vermersch, Thomas Berger, Thomas Berger
Published 2022-10-01
Article -
12
-
13
-
14
The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis by Martin Vališ, Anat Achiron, Hans Peter Hartung, Jan Mareš, Veronika Tichá, Pavel Štourač, Simona Halusková, Francesco Angelucci, Zbyšek Pavelek
Published 2023-08-01
Article -
15
-
16
Glatiramer Acetate Treatment in Multiple Sclerosis-Associated Fatigue—Beneficial Effects on Self-Assessment Scales But Not on Molecular Markers by Oliver Neuhaus, Wolfgang Köhler, Florian Then Bergh, Wolfgang Kristoferitsch, Jürgen Faiss, Thorsten Rosenkranz, Dirk Reske, Robert Patejdl, Hans-Peter Hartung, Uwe K. Zettl
Published 2021-03-01
Article -
17
-
18
-
19
-
20